| Literature DB >> 26527170 |
Jingya Lyu1, Hitomi Imachi1, Kensaku Fukunaga1, Takuo Yoshimoto1, Huanxiang Zhang1, Koji Murao1.
Abstract
Infection by hepatitis C virus (HCV), a plus-stranded RNA virus that can cause cirrhosis and hepatocellular carcinoma, is one of the major health problems in the world. HCV infection is considered as a multi-step complex process and correlated with abnormal metabolism of lipoprotein. In addition, virus attacks hepatocytes by the initial attaching viral envelop glycoprotein E1/E2 to receptors of lipoproteins on host cells. With the development of HCV model system, mechanisms of HCV cell entry through lipoprotein uptake and its receptor have been extensively studied in detail. Here we summarize recent knowledge about the role of lipoprotein receptors, scavenger receptor class B type I and low-density lipoprotein receptor in the entry of HCV, providing a foundation of novel targeting therapeutic tools against HCV infection.Entities:
Keywords: CD81; Hepatitis C virus entry; Lipoprotein receptors; Low-density lipoprotein receptor; Scavenger receptor class B type I
Year: 2015 PMID: 26527170 PMCID: PMC4621467 DOI: 10.4254/wjh.v7.i24.2535
Source DB: PubMed Journal: World J Hepatol